Japan Clears First All-Oral Hepatitis C Treatment Japan Clears First All-Oral Hepatitis C Treatment

The daclatasvir plus asunaprevir combination is indicated for patients with genotype 1 chronic hepatitis C virus who cannot take or do not respond to traditional therapies. International Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Alert Source Type: news